Serum Irisin Level is Higher and Related with Insulin in Acanthosis Nigricans-related Obesity

Experimental and Clinical Endocrinology and Diabetes

Volumn 124, Issue 3, 2016, Pages 203-207

  Chen, J Q ^a,b   Fang, L J ^b   Song, K X ^a   Wang, X C ^a,b   Huang, Y Y ^a   Chai, S Y ^a   Bu, L ^a   Qu, S ^a,b  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

acanthosis nigricans; hyperinsulinemia; irisin; obesity

Indexed keywords

INSULIN; IRISIN; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ACANTHOSIS NIGRICANS; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; BLOOD; CLINICAL TRIAL; COMPLICATION; HYPERINSULINISM; METABOLISM; PANCREAS ISLET BETA CELL;

ACANTHOSIS NIGRICANS; ADULT; FIBRONECTINS; HUMANS; HYPERINSULINISM; INSULIN; INSULIN-SECRETING CELLS; OBESITY;

EID: 84947966919     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0035-1565060     Document Type: Article

References (29)

1. Jones L. H., Ficca M. Is Acanthosis Nigricans a reliable indicator for risk of type 2 diabetes? J Sch Nurs: 2007; 23 247 251
2. Sinha S., Schwartz R. A. Juvenile acanthosis nigricans. J Am Acad Dermatol: 2007; 57 502 508
3. Bostrom P., Wu J., Jedrychowski M. P. et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature: 2012; 481 463 468
4. Liu J. J., Wong M. D., Toy W. C. et al. Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications: 2013; 27 365 369
5. Huh J. Y., Panagiotou G., Mougios V. et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. MRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism: 2012; 61 1725 1738
6. Crujeiras A. B., Pardo M., Arturo R. R. et al. Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women. Am J Um Biol: 2014; 26 198 207
7. de la Iglesia R., Lopez-Legarrea P., Crujeiras A. B. et al. Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients. Clin Endocrinol (Oxf): 2014; 81 306 311
8. Choi Y. K., Kim M. K., Bae K. H. et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract: 2013; 100 96 101
9. Moreno-Navarrete J. M., Ortega F., Serrano M. et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab: 2013; 98 E769 E778
10. Xiang L., Xiang G., Yue L. et al. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. Atherosclerosis: 2014; 235 328 333
11. Zhang M., Chen P., Chen S. et al. The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: A preliminary study. Eur Rev Med Pharmacol Sci: 2014; 18 1567 1572
12. Burke J. P., Hale D. E., Hazuda H. P. et al. A quantitative scale of acanthosis nigricans. Diabetes Care: 1999; 22 1655 1659
13. Zaridoust A., Rabbani A., Sayarifard F. et al. Acanthosis nigricans, abnormal facial appearance and dentition in an insulin resistance syndrome. Iran J Pediatr: 2013; 23 363 365
14. Kluczynik C. E., Mariz L. S., Souza L. C. et al. Acanthosis nigricans and insulin resistance in overweight children and adolescents. An Bras Dermatol: 2012; 87 531 537
15. Guilherme A., Virbasius J. V., Puri V. et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol: 2008; 9 367 377
16. Handschin C., Spiegelman B. M. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature: 2008; 454 463 469
17. Yan J., Feng Z., Liu J. et al. Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: Ameliorating effects of (-)-epigallocatechin-3-gallate. J Nutr Biochem: 2012; 23 716 724
18. Guilherme A., Virbasius J. V., Puri V. et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol: 2008; 9 367 377
19. Holloszy J. O. Skeletal muscle "mitochondrial deficiency" does not mediate insulin resistance. Am J Clin Nutr: 2009; 89 463S 466S
20. Jackson J. R., Ryan M. J., Alway S. E. Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice. J Gerontol A Biol Sci Med Sci: 2011; 66 751 764
21. Muoio D. M., Koves T. R. Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1 alpha: Implications for metabolic disease. Appl Physiol Nutr Metab: 2007; 32 874 883
22. Hee P. K., Zaichenko L., Brinkoetter M. et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J Clin Endocrinol Metab: 2013; 98 4899 4907
23. Stengel A., Hofmann T., Goebel-Stengel M. et al. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - correlation with body mass index. Peptides: 2013; 39 125 130
24. Pardo M., Crujeiras A. B., Amil M. et al. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol. 2014; 2014 857270
25. Liu J. J., Liu S., Wong M. D. et al. Relationship between circulating irisin, renal function and body composition in type 2 diabetes. J Diabetes Complications: 2014; 28 208 213
26. Masoodi M., Kuda O., Rossmeisl M. et al. Lipid signaling in adipose tissue: Connecting inflammation & metabolism. Biochim Biophys Acta: 2014
27. Sanz Y., Moya-Perez A. Microbiota inflammation and obesity. Adv Exp Med Biol: 2014; 817 291 317
28. Panagiotou G., Mu L., Na B. et al. Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk. Metabolism: 2014; 63 1265 1271
29. Zhang H. J., Zhang X. F., Ma Z. M. et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol: 2013; 59 557 562